Celadon Pharmaceuticals (CEL) Stock Chart & Stock Price History GBX 6.99 -0.16 (-2.24%) As of 10:55 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Celadon Pharmaceuticals Stock Price Performance 5 Day Performance-0.14%1 Month Performance-50.95%3 Month Performance-78.16%6 Month Performance-78.16%Year-To-Date Performance-50.07%1 Year Performance-93.65% Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CEL Stock Chart for Wednesday, April, 16, 2025 CEL Chart by TradingViewRemove Ads Celadon Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/15/2025GBX 6.40GBX 7.15+11.81%GBX 7.15GBX 616,503 shs£4.39 million04/14/2025GBX 7GBX 6.40-8.64%GBX 7GBX 6.35143,076 shs£3.92 million04/11/2025GBX 6.70GBX 7+4.48%GBX 7GBX 6.15450,978 shs£4.29 million04/10/2025GBX 6.75GBX 6.70-0.74%GBX 7GBX 61.27 million shs£4.11 million04/09/2025GBX 5.20GBX 6.75+29.81%GBX 7GBX 42.36 million shs£4.14 million04/09/2025GBX 5.20GBX 6.75+29.81%GBX 7GBX 42.36 million shs£4.14 million04/08/2025GBX 7GBX 5.20-25.71%GBX 7GBX 3.31427,378 shs£3.19 million04/08/2025GBX 7GBX 5.20-25.71%GBX 7GBX 3.31427,378 shs£3.19 million04/07/2025GBX 4.11GBX 7+70.32%GBX 7GBX 41.49 million shs£4.29 million04/04/2025GBX 5.41GBX 4.11-24.03%GBX 6.10GBX 3.16626,330 shs£2.52 million Get the Latest News and Ratings for CEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/03/2025GBX 6.10GBX 5.41-11.31%GBX 8GBX 5.11580,088 shs£3.32 million04/02/2025GBX 3GBX 6.10+103.33%GBX 8GBX 2.76775,934 shs£3.74 million04/01/2025GBX 6.12GBX 3-50.98%GBX 4GBX 2.40579,069 shs£1.84 million03/31/2025GBX 8.75GBX 6.12-30.06%GBX 9GBX 3.10908,568 shs£3.75 million03/28/2025GBX 8GBX 8.75+9.38%GBX 9GBX 7258,806 shs£5.37 million03/27/2025GBX 9.60GBX 8-16.67%GBX 11GBX 7353,043 shs£4.91 million03/26/2025GBX 9.50GBX 9.60+1.05%GBX 10.40GBX 8.38299,917 shs£5.89 million03/25/2025GBX 10.87GBX 9.50-12.58%GBX 10.10GBX 8.38757,802 shs£5.83 million03/24/2025GBX 15GBX 10.87-27.55%GBX 11.70GBX 5788,720 shs£6.67 million03/21/2025GBX 13.33GBX 15+12.53%GBX 15GBX 13162,550 shs£9.20 million03/20/2025GBX 13.80GBX 13.33-3.41%GBX 15GBX 13.33141,613 shs£8.18 million03/19/2025GBX 13.88GBX 13.80-0.58%GBX 15GBX 7.38530,653 shs£8.46 million03/18/2025GBX 14GBX 13.88-0.86%GBX 14GBX 1344,608 shs£8.51 million03/17/2025GBX 14.25GBX 14-1.75%GBX 16GBX 13.14165,447 shs£8.59 million Related Companies Cambridge Nutritional Sciences Stock Chart Beacon Energy Stock Chart Fox Marble Stock Chart Curzon Energy Stock Chart Vodafone Group Public Stock Chart BT Group Stock Chart BBGI Global Infrastructure Stock Chart Pacific Horizon Investment Trust Stock Chart Provexis Stock Chart Argent BioPharma Stock Chart Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CEL) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celadon Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Celadon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CEL Stock Free CEL Stock Alerts